Connection

Cristina Gervasoni to Antiretroviral Therapy, Highly Active

Back to Details
This is a "connection" page, showing publications Cristina Gervasoni has written about Antiretroviral Therapy, Highly Active.
Cristina Gervasoni
Connection Strength
0.758
Antiretroviral Therapy, Highly Active
  1. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021 05; 22(5):372-378.
    View in: PubMed
    Score: 0.574
  2. Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations. Eur J Drug Metab Pharmacokinet. 2017 Aug; 42(4):559-572.
    View in: PubMed
    Score: 0.113
  3. Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study. Arch Intern Med. 2002 Dec 9-23; 162(22):2621-8.
    View in: PubMed
    Score: 0.041
  4. Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice. Antivir Ther. 2018; 23(3):249-257.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.